Island Pharma Jumps After Emergency-Use Approval for Ebola Drug

Source: bloombergMarkets July 6, 2026 · 17:52
Australia’s Island Pharmaceuticals Ltd. surged as much as 47% after saying its experimental antiviral galidesivir had secured regulatory and ethics approvals for emergency use in patients with the Bundibugyo strain of Ebola in Uganda.

The original article opens on the publisher's website.

More from Mobile

View topic →
Countries mentioned